Risk factor
Good trading liquidity
Profitability factor
Weak growth
About
Dian Diagnostics Group Co.,Ltd. operates as a third-party independent medical diagnostic service company in China. It offers medical diagnosis solutions for various general hospitals and specialty hospitals, community health service centers, township health centers, physical examination centers, disease prevention and control centers, and other medical and health institutions. The company operates 40 chain laboratories worldwide. It also engages in the research, development, and production of in vitro diagnostic reagents and related equipment and consumables; provision of medical equipment, drugs, clinical samples, biological products, virus and microorganisms, finished blood, live animals, compounds, and diagnostic reagents, as well as other cold chain transportation, warehousing services, cold chain product sales, and technical services. The company was formerly known as Zhejiang DIAN Diagnostics Co., Ltd. and changed its name to Dian Diagnostics Group Co.,Ltd. in November 2017. Dian Diagnostics Group Co.,Ltd. was founded in 2001 and is based in Hangzhou, China.
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. In particular, the stock is reasonably priced on P/E, of fair value on EV/EBITDA,
Target Price
The average target price of 300244.SZ is 14 and suggests 28% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to
Buy
Sell